Your browser doesn't support javascript.
loading
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.
Desai, Ami V; Applebaum, Mark A; Karrison, Theodore G; Oppong, Akosua; Yuan, Cindy; Berg, Katherine R; MacQuarrie, Kyle; Sokol, Elizabeth; Hall, Anurekha G; Pinto, Navin; Wolfe, Ian; Mody, Rajen; Shusterman, Suzanne; Smith, Valeria; Foster, Jennifer H; Nassin, Michele; LaBelle, James L; Bagatell, Rochelle; Cohn, Susan L.
Affiliation
  • Desai AV; Department of Pediatrics, University of Chicago, Chicago, Illinois.
  • Applebaum MA; Department of Pediatrics, University of Chicago, Chicago, Illinois.
  • Karrison TG; Department of Public Health Sciences, University of Chicago, Chicago, Illinois.
  • Oppong A; Pritzker School of Medicine, University of Chicago, Chicago, Illinois.
  • Yuan C; Department of Radiology, University of Chicago, Chicago, Illinois.
  • Berg KR; Children's Hospital of Philadelphia and the University of Pennsylvania, Philadelphia, Pennsylvania.
  • MacQuarrie K; Ann and Robert H. Lurie Children's Hospital of Chicago and Northwestern University, Chicago, Illinois.
  • Sokol E; Ann and Robert H. Lurie Children's Hospital of Chicago and Northwestern University, Chicago, Illinois.
  • Hall AG; Seattle Children's Hospital and University of Washington, Seattle, Washington.
  • Pinto N; Seattle Children's Hospital and University of Washington, Seattle, Washington.
  • Wolfe I; C. S. Mott Children's Hospital and University of Michigan, Ann Arbor, Michigan.
  • Mody R; C. S. Mott Children's Hospital and University of Michigan, Ann Arbor, Michigan.
  • Shusterman S; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts.
  • Smith V; Texas Children's Hospital and Baylor College of Medicine, Houston, Texas.
  • Foster JH; Texas Children's Hospital and Baylor College of Medicine, Houston, Texas.
  • Nassin M; Department of Pediatrics, University of Chicago, Chicago, Illinois.
  • LaBelle JL; Department of Pediatrics, University of Chicago, Chicago, Illinois.
  • Bagatell R; Children's Hospital of Philadelphia and the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Cohn SL; Department of Pediatrics, University of Chicago, Chicago, Illinois.
Cancer ; 128(15): 2967-2977, 2022 08 01.
Article in En | MEDLINE | ID: mdl-35665495

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Neuroblastoma Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Year: 2022 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Neuroblastoma Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Year: 2022 Document type: Article Country of publication: United States